China pushes for lower cancer drug prices: Xinhua

“A national medical insurance system began covering 16 brands of targeted cancer drugs last year, cutting prices by 44 percent on average, Xinhua reported this year” writes Midwest Communications Inc for SHANGHAI (Reuters) – China’s new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday.

Share This:

Related posts